Restoring America

Conservative values, National renewal

Americans want big pharma reform. Candidates should deliver

Published



Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why when a new national survey shows 94% of voters blame pharmaceutical companies for the high cost of healthcare, it demands our serious attention. The American people are speaking with one voice, and every candidate running in the 2026 midterm elections should be listening.

Americans know that Big Pharma’s pricing tactics have gotten out of control, and the vast majority — 89% — are demanding drug pricing reform. The case for it is straightforward. What exists in the pharmaceutical industry today is a rigged game, where patent manipulation, price-gouging, and a lobbying machine keep life-saving drugs out of reach for most people.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.